Invention Application
- Patent Title: EPIGENETIC MECHANISMS OF ANTI-FIBROTIC ACTION FOR THE LIVER
- Patent Title (中): 用于肝脏的抗纤维化作用的机制
-
Application No.: US13691604Application Date: 2012-11-30
-
Publication No.: US20130137649A1Publication Date: 2013-05-30
- Inventor: Hidekazu Tsukamoto , Clay Wang
- Applicant: UNIVERSITY OF SOUTHERN CALIFORNIA
- Applicant Address: US CA Los Angeles
- Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA
- Current Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA
- Current Assignee Address: US CA Los Angeles
- Main IPC: A61K31/7048
- IPC: A61K31/7048 ; A61K31/216
Abstract:
This invention demonstrates the therapeutic efficacy of Yang-Gan-Wan (YGW) and its active components, especially in the formulation provided by Sheng-Pu Pharmaceutials, Inc., for treating and preventing liver fibrosis. This invention further demonstrates MeCP2 is an important therapeutic target for YGW and its active ingredients' action against liver fibrosis and cirrhosis.
Information query
